Caplin Point Laboratories Limited (CAPLIPOINT.NS)
- Previous Close
1,314.95 - Open
1,312.00 - Bid --
- Ask --
- Day's Range
1,281.60 - 1,314.95 - 52 Week Range
712.00 - 1,619.05 - Volume
57,171 - Avg. Volume
109,107 - Market Cap (intraday)
97.957B - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
21.55 - EPS (TTM)
59.87 - Earnings Date Aug 5, 2024 - Aug 9, 2024
- Forward Dividend & Yield 5.00 (0.37%)
- Ex-Dividend Date May 31, 2024
- 1y Target Est
--
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. It provides liquid and lyophilized vials, pre-filled syringes, 3-pc ophthalmic droppers, pre-mix bags, dry and liquid syrups-bottles, tables, soft gels, capsules, suppositories, liquid and emulsion injectables in ampoules and vials, topicals, and sachets. The company was incorporated in 1990 and is headquartered in Chennai, India.
www.caplinpoint.net1,642
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: CAPLIPOINT.NS
Performance Overview: CAPLIPOINT.NS
Trailing total returns as of 5/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CAPLIPOINT.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CAPLIPOINT.NS
Valuation Measures
Market Cap
101.65B
Enterprise Value
93.31B
Trailing P/E
22.39
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.04
Price/Book (mrq)
4.40
Enterprise Value/Revenue
5.51
Enterprise Value/EBITDA
15.08
Financial Highlights
Profitability and Income Statement
Profit Margin
26.82%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
16.32B
Net Income Avi to Common (ttm)
4.38B
Diluted EPS (ttm)
59.87
Balance Sheet and Cash Flow
Total Cash (mrq)
6.87B
Total Debt/Equity (mrq)
0.16%
Levered Free Cash Flow (ttm)
--
Research Analysis: CAPLIPOINT.NS
Company Insights: CAPLIPOINT.NS
CAPLIPOINT.NS does not have Company Insights